ONCY

Quote

Short

News

Articles

Message Board

Oncolytics Biotech Inc. (NASDAQ : ONCY ) News

Oncolytics Biotech Inc. (NASDAQ: ONCY) News Releases

ONCY News Releases

June 01, 2026 09:00:00 am

GlobeNewswire

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

May 26, 2026 09:00:00 am

ACCESS Newswire

From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story

May 22, 2026 09:00:00 am

GlobeNewswire

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep's Potential Across Gastrointestinal Tumors

May 14, 2026 10:55:00 am

GlobeNewswire

"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies

May 04, 2026 09:00:00 am

GlobeNewswire

Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer

April 27, 2026 08:10:00 am

GlobeNewswire

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

April 25, 2026 04:27:34 am

SeekingAlpha

Oncolytics Could Re-Rate As Pelareorep Focuses On Registrational Paths

April 06, 2026 09:00:00 am

GlobeNewswire

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer

April 01, 2026 11:32:42 am

Zolmax

Oncolytics Biotech (NASDAQ:ONCY) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS

April 01, 2026 09:00:00 am

GlobeNewswire

Oncolytics Biotech® Completes Domicile Change to the United States

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account